|
US5605906A
(en)
|
1995-03-24 |
1997-02-25 |
Merck Frosst Canada, Inc. |
Cannabinoid receptor agonists
|
|
JP3964478B2
(ja)
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
|
US5971080A
(en)
|
1997-11-26 |
1999-10-26 |
Central Sprinkler Corporation |
Quick response dry pipe sprinkler system
|
|
US7308894B2
(en)
|
1998-06-03 |
2007-12-18 |
Scott Laboratories, Inc. |
Apparatuses and methods for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures according to appropriate clinical heuristics
|
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
|
IL150302A
(en)
|
2002-01-31 |
2008-07-08 |
Naim Menashe |
Bicyclic cb2 cannabinoid receptor ligands
|
|
SE0300010D0
(sv)
|
2003-01-07 |
2003-01-07 |
Astrazeneca Ab |
Novel Compounds
|
|
ITMI20041033A1
(it)
|
2004-05-24 |
2004-08-24 |
Neuroscienze S C A R L |
Composti farmaceutici
|
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
|
EP2343302A1
(en)
|
2004-07-12 |
2011-07-13 |
Cadila Healthcare Limited |
Tricyclic pyrazole derivatives as cannabinoid receptor modulators
|
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
|
FR2875230A1
(fr)
|
2004-09-13 |
2006-03-17 |
Sanofi Aventis Sa |
Derives de pyrazole condense, leur preparation et leur application en therapeutique
|
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
|
CA2613678A1
(en)
|
2005-06-02 |
2006-12-07 |
Glenmark Pharmaceuticals S.A. |
Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
|
US7597910B2
(en)
|
2005-08-20 |
2009-10-06 |
Slgm Medical Research Institute |
Compositions and methods for treating prostate disorders
|
|
BRPI0616263A2
(pt)
|
2005-09-23 |
2011-06-14 |
Janssen Pharmaceutica Nv |
moduladores canabinàides do tipo tetrahidro-ciclopentil pirazol
|
|
ATE459352T1
(de)
|
2006-07-04 |
2010-03-15 |
Janssen Pharmaceutica Nv |
Benzimidazol-cannabinoid-agonisten mit einer substituierten heterocyclischen gruppe
|
|
US7928123B2
(en)
|
2006-09-25 |
2011-04-19 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
|
US8481574B2
(en)
|
2006-10-12 |
2013-07-09 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
|
WO2008048914A1
(en)
|
2006-10-17 |
2008-04-24 |
Boehringer Ingelheim International Gmbh |
Polycyclic compounds which modulate the cb2 receptor
|
|
EP2091921A2
(en)
|
2006-11-03 |
2009-08-26 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
|
US8173638B2
(en)
|
2006-11-21 |
2012-05-08 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
|
US9763894B2
(en)
|
2006-12-05 |
2017-09-19 |
Virginia Commonwealth University |
Inflammation therapy
|
|
WO2008085302A1
(en)
|
2006-12-20 |
2008-07-17 |
Merck & Co., Inc. |
Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
|
|
US20080161340A1
(en)
|
2006-12-20 |
2008-07-03 |
Cara Therapeutics, Inc. |
Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof
|
|
US20080214537A1
(en)
|
2007-03-02 |
2008-09-04 |
Cara Therapeutics, Inc. |
Bridged phenanthridines
|
|
US8193369B2
(en)
|
2007-03-30 |
2012-06-05 |
Janssen Pharmaceutica Nv |
Benzimidazole cannabinoid agonists
|
|
WO2008157500A1
(en)
|
2007-06-17 |
2008-12-24 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
CN101686989B
(zh)
|
2007-06-21 |
2016-10-19 |
卡拉治疗学股份有限公司 |
取代的咪唑并杂环
|
|
US8338623B2
(en)
|
2007-07-09 |
2012-12-25 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
|
US7943658B2
(en)
|
2007-07-23 |
2011-05-17 |
Bristol-Myers Squibb Company |
Indole indane amide compounds useful as CB2 agonists and method
|
|
EP2203171A2
(en)
|
2007-08-21 |
2010-07-07 |
Merck Sharp & Dohme Corp. |
Cb2 receptor ligands for the treatment of pain
|
|
UA104010C2
(en)
|
2008-12-18 |
2013-12-25 |
Эли Лилли Энд Компани |
Purine compounds
|
|
WO2010088050A2
(en)
|
2009-01-28 |
2010-08-05 |
Cara Therapeutics, Inc. |
Bicyclic pyrazolo-heterocycles
|
|
US7741350B1
(en)
|
2009-01-28 |
2010-06-22 |
Cara Therapeutics, Inc. |
Bicyclic pyrazolo-heterocycles
|
|
IN2012DN02474A
(https=)
*
|
2009-08-28 |
2015-08-21 |
Arena Pharm Inc |
|
|
AU2012222149B2
(en)
|
2011-02-25 |
2017-06-29 |
Arena Pharmaceuticals, Inc. |
Cannabinoid receptor modulators
|
|
EP2678330A1
(en)
*
|
2011-02-25 |
2014-01-01 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators)
|
|
WO2012116278A1
(en)
|
2011-02-25 |
2012-08-30 |
Arena Pharmaceuticals, Inc. |
Cannabinoid receptor modulators
|
|
US9597340B2
(en)
|
2011-02-25 |
2017-03-21 |
Arena Pharmaceuticals, Inc. |
Cannabinoid receptor modulators
|
|
WO2016085941A1
(en)
|
2014-11-25 |
2016-06-02 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of cannabinoid receptor modulators
|
|
WO2017039643A1
(en)
|
2015-09-01 |
2017-03-09 |
Arena Pharmaceuticals, Inc. |
Cb2 receptor internalization
|
|
AU2017249211A1
(en)
|
2016-04-10 |
2018-11-22 |
Arena Pharmaceuticals, Inc. |
Methods of treatment with selective CB2 receptor agonists
|
|
US20200078358A1
(en)
|
2017-05-08 |
2020-03-12 |
Arena Pharmaceuticals, Inc. |
Compounds and Methods for Treatment of Visceral Pain
|
|
WO2018208847A1
(en)
*
|
2017-05-08 |
2018-11-15 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of pain from inflammatory bowel disease
|
|
US12357604B2
(en)
*
|
2017-09-22 |
2025-07-15 |
Inmed Pharmaceuticals Inc. |
Topical formulations of cannabinoids and use thereof in the treatment of pain
|
|
US20240165109A1
(en)
*
|
2021-03-02 |
2024-05-23 |
Arena Pharmaceuticals, Inc. |
Methods of Treatment with Selective CB2 Receptor Agonists
|
|
TW202330496A
(zh)
*
|
2021-10-05 |
2023-08-01 |
美商艾尼納製藥公司 |
用於製備大麻素受體調節劑之結晶形式及方法
|